• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在Caco-2细胞中对一系列中链脂肪酸肠道渗透增强剂进行的直接多参数高内涵分析。

A head-to-head multi-parametric high content analysis of a series of medium chain fatty acid intestinal permeation enhancers in Caco-2 cells.

作者信息

Brayden David J, Gleeson John, Walsh Edwin G

出版信息

Eur J Pharm Biopharm. 2014 Nov;88(3):830-39. doi: 10.1016/j.ejpb.2014.10.008.

DOI:10.1016/j.ejpb.2014.10.008
PMID:25460147
Abstract

There is debate over the narrow safety margin of many oral permeation enhancers. The sodium salts of medium chain fatty acids (MCFAs) are components of selected oral peptide formulations being assessed in advanced clinical studies. The aim of the study was to examine the effects of the C8-C12 series on filter-grown Caco-2 monolayers and cells grown on 96 well plates in order to dissect the relationship between paracellular permeability enhancement (Papp of [14C]mannitol, reduction in TEER), critical micellar concentration (CMC), and sub-lethal cytotoxicity (high content analysis (HCA). There was a high degree of correlation between the EC50 for increasing the Papp with reduction in transepithelial electrical resistance (TEER), and with CMC values. C8 had the highest EC50 and highest CMC value and was the least cytotoxic, while C12 had the reverse, suggesting a close association between increases in chain length with increases in permeability, hydrophobicity and cytotoxicity. HCA revealed further association between MCFA-induced intracellular calcium increases and plasma membrane permeability reductions in Caco-2 cells with the EC50 to increase the Papp across monolayers. HCA identified sub-lethal cytotoxicity in a series of MCFA and related cell parameters to physicochemical properties and efficacy as intestinal permeation enhancers. These mild surfactants therefore non-specifically partition into the plasma membrane causing membrane fluidization, which is associated with concentration-dependent increases in permeability.

摘要

许多口服渗透促进剂的安全边际较窄,对此存在争议。中链脂肪酸(MCFAs)的钠盐是正在进行高级临床研究评估的特定口服肽制剂的成分。本研究的目的是研究C8 - C12系列对滤膜生长的Caco - 2单层细胞和96孔板上生长的细胞的影响,以剖析细胞旁通透性增强([14C]甘露醇的表观渗透系数Papp,跨上皮电阻TEER降低)、临界胶束浓度(CMC)和亚致死细胞毒性(高内涵分析(HCA))之间的关系。增加Papp的半数有效浓度(EC50)与跨上皮电阻(TEER)降低以及与CMC值之间存在高度相关性。C8的EC50最高且CMC值最高,细胞毒性最小,而C12则相反,这表明链长增加与通透性、疏水性和细胞毒性增加之间存在密切关联。HCA揭示了MCFA诱导的Caco - 2细胞内钙增加与质膜通透性降低之间的进一步关联,以及跨单层增加Papp的EC50。HCA确定了一系列MCFA中的亚致死细胞毒性以及与作为肠道渗透促进剂的理化性质和功效相关的细胞参数。因此,这些温和的表面活性剂非特异性地分配到质膜中,导致膜流动性增加,这与浓度依赖性的通透性增加有关。

相似文献

1
A head-to-head multi-parametric high content analysis of a series of medium chain fatty acid intestinal permeation enhancers in Caco-2 cells.在Caco-2细胞中对一系列中链脂肪酸肠道渗透增强剂进行的直接多参数高内涵分析。
Eur J Pharm Biopharm. 2014 Nov;88(3):830-39. doi: 10.1016/j.ejpb.2014.10.008.
2
A head-to-head Caco-2 assay comparison of the mechanisms of action of the intestinal permeation enhancers: SNAC and sodium caprate (C).Caco-2 细胞模型中肠渗透促进剂:N-乙酰半胱氨酸和癸酸钠(C)作用机制的头对头比较。
Eur J Pharm Biopharm. 2020 Jul;152:95-107. doi: 10.1016/j.ejpb.2020.04.023. Epub 2020 May 6.
3
Evaluation of alkylmaltosides as intestinal permeation enhancers: comparison between rat intestinal mucosal sheets and Caco-2 monolayers.评价烷基麦芽苷作为肠道渗透促进剂的效果:大鼠肠黏膜片与 Caco-2 单层细胞的比较。
Eur J Pharm Sci. 2012 Nov 20;47(4):701-12. doi: 10.1016/j.ejps.2012.08.010. Epub 2012 Aug 23.
4
Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell monolayers.中链脂肪酸在肠上皮Caco-2细胞单层中增强吸收的机制。
J Pharmacol Exp Ther. 1995 Nov;275(2):958-64.
5
Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol.米索前列醇可预防癸酸钠诱导的肠道通透性增加和上皮损伤。
Eur J Pharm Biopharm. 2015 Aug;94:194-206. doi: 10.1016/j.ejpb.2015.05.013. Epub 2015 May 27.
6
Labrasol and Salts of Medium-Chain Fatty Acids Can Be Combined in Low Concentrations to Increase the Permeability of a Macromolecule Marker Across Isolated Rat Intestinal Mucosae.低浓度的 Labrasol 和中链脂肪酸盐可以联合使用,增加大分子标记物穿过离体大鼠肠黏膜的通透性。
J Pharm Sci. 2018 Jun;107(6):1648-1655. doi: 10.1016/j.xphs.2018.02.012. Epub 2018 Feb 17.
7
Evaluation of cytotoxicity of surfactants used in self-micro emulsifying drug delivery systems and their effects on paracellular transport in Caco-2 cell monolayer.评价自微乳药物传递系统中所用表面活性剂的细胞毒性及其对 Caco-2 细胞单层细胞旁通透性的影响。
Eur J Pharm Sci. 2012 Oct 9;47(3):564-73. doi: 10.1016/j.ejps.2012.07.005. Epub 2012 Jul 27.
8
Investigations of Piperazine Derivatives as Intestinal Permeation Enhancers in Isolated Rat Intestinal Tissue Mucosae.哌嗪衍生物作为肠道渗透促进剂在离体大鼠肠黏膜中的研究。
AAPS J. 2020 Jan 27;22(2):33. doi: 10.1208/s12248-020-0416-9.
9
Fatty acids increase paracellular absorption of aluminium across Caco-2 cell monolayers.脂肪酸可增加铝通过Caco-2细胞单层的细胞旁吸收。
Chem Biol Interact. 2009 Oct 7;181(2):272-8. doi: 10.1016/j.cbi.2009.06.016. Epub 2009 Jul 2.
10
Permeability-enhancing effects of three laurate-disaccharide monoesters across isolated rat intestinal mucosae.三种月桂酸二糖单酯对离体大鼠肠黏膜的通透性增强作用。
Int J Pharm. 2021 May 15;601:120593. doi: 10.1016/j.ijpharm.2021.120593. Epub 2021 Apr 20.

引用本文的文献

1
Modification of Peptide and Permeation Enhancer In Vitro Release Rates by Dispersion with a Gel-Forming Polymer.通过与凝胶形成聚合物分散来改变肽和渗透促进剂的体外释放速率
Pharm Res. 2025 Jun 6. doi: 10.1007/s11095-025-03870-y.
2
Gastrointestinal Permeation Enhancers Beyond Sodium Caprate and SNAC - What is Coming Next?超越癸酸钠和 SNAC 的胃肠道渗透增强剂 - 接下来会有什么?
Adv Sci (Weinh). 2024 Sep;11(33):e2400843. doi: 10.1002/advs.202400843. Epub 2024 Jun 17.
3
Oral Absorption of Middle-to-Large Molecules and Its Improvement, with a Focus on New Modality Drugs.
中大分子的口服吸收及其改善,重点关注新型药物
Pharmaceutics. 2023 Dec 28;16(1):47. doi: 10.3390/pharmaceutics16010047.
4
SNAC for Enhanced Oral Bioavailability: An Updated Review.SNAC 增强口服生物利用度:最新综述。
Pharm Res. 2023 Mar;40(3):633-650. doi: 10.1007/s11095-022-03459-9. Epub 2022 Dec 20.
5
Impact of Intestinal Concentration and Colloidal Structure on the Permeation-Enhancing Efficiency of Sodium Caprate in the Rat.肠道浓度和胶态结构对癸酸钠在大鼠体内渗透增强效率的影响。
Mol Pharm. 2022 Jan 3;19(1):200-212. doi: 10.1021/acs.molpharmaceut.1c00724. Epub 2021 Dec 20.
6
In Silico-Based Experiments on Mechanistic Interactions between Several Intestinal Permeation Enhancers with a Lipid Bilayer Model.基于计算机的几种肠道渗透增强剂与脂质双层模型的相互作用机制的实验研究。
Mol Pharm. 2022 Jan 3;19(1):124-137. doi: 10.1021/acs.molpharmaceut.1c00689. Epub 2021 Dec 16.
7
Electron Spin Resonance Evaluation of Buccal Membrane Fluidity Alterations by Sodium Caprylate and L-Menthol.用辛酸钠和L-薄荷醇对颊膜流动性改变进行电子自旋共振评估。
Int J Mol Sci. 2021 Oct 2;22(19):10708. doi: 10.3390/ijms221910708.
8
Oral delivery of peptide therapeutics in infants: Challenges and opportunities.婴儿经口递呈肽类治疗药物:挑战与机遇。
Adv Drug Deliv Rev. 2021 Jun;173:112-124. doi: 10.1016/j.addr.2021.03.011. Epub 2021 Mar 25.
9
A nanoemulsion/micelles mixed nanosystem for the oral administration of hydrophobically modified insulin.一种用于口服给药的疏水性修饰胰岛素的纳米乳液/胶束混合纳米系统。
Drug Deliv Transl Res. 2021 Apr;11(2):524-545. doi: 10.1007/s13346-021-00920-x. Epub 2021 Feb 11.
10
Influence of Bile Composition on Membrane Incorporation of Transient Permeability Enhancers.胆汁成分对瞬时通透性增强剂膜嵌入的影响。
Mol Pharm. 2020 Nov 2;17(11):4226-4240. doi: 10.1021/acs.molpharmaceut.0c00668. Epub 2020 Oct 8.